Modulatory Effects of Nicotine on neuroHIV/neuroAIDS

[1]  T. Gould,et al.  Cigarette smoke and nicotine effects on brain proinflammatory responses and behavioral and motor function in HIV-1 transgenic rats , 2018, Journal of NeuroVirology.

[2]  Ming D. Li,et al.  HIV-1 Proteins Influence Novelty-Seeking Behavior and Alter Region-Specific Transcriptional Responses to Chronic Nicotine Treatment in HIV-1Tg Rats , 2017, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[3]  V. Sagar,et al.  Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS , 2017, PloS one.

[4]  Lei Zhang,et al.  Network and Pathway-Based Analyses of Genes Associated with Parkinson’s Disease , 2016, Molecular Neurobiology.

[5]  Lei Zhang,et al.  Analyzing the genes related to Alzheimer’s disease via a network and pathway-based approach , 2017, Alzheimer's Research & Therapy.

[6]  Linda Chang,et al.  Chronic Tobacco-Smoking on Psychopathological Symptoms, Impulsivity and Cognitive Deficits in HIV-Infected Individuals , 2017, Journal of Neuroimmune Pharmacology.

[7]  C. Mactutus,et al.  Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1 , 2016, Journal of NeuroVirology.

[8]  Shengdi Chen,et al.  Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease , 2016, Progress in Neurobiology.

[9]  D. Kazan,et al.  Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. , 2016 .

[10]  Ming D. Li,et al.  Interactive Effects of Ethanol and HIV-1 Proteins on Novelty-Seeking Behaviors and Addiction-Related Gene Expression. , 2016, Alcoholism, clinical and experimental research.

[11]  R. Steinbrook HIV/AIDS in 2016 and Beyond. , 2016, Journal of the American Medical Association (JAMA).

[12]  D. Klein,et al.  Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care , 2016, Journal of acquired immune deficiency syndromes.

[13]  J. Joseph,et al.  HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities. , 2016, Current HIV research.

[14]  Reed J. D. Sorensen,et al.  Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 , 2016, The lancet. HIV.

[15]  Ryung S. Kim,et al.  Gender Differences among Smokers Living with HIV , 2016, Journal of the International Association of Providers of AIDS Care.

[16]  Ming D. Li,et al.  Modulation Effect of HIV-1 Viral Proteins and Nicotine on Expression of the Immune-Related Genes in Brain of the HIV-1 Transgenic Rats , 2016, Journal of Neuroimmune Pharmacology.

[17]  Ming D. Li,et al.  Expression profile of nicotinic acetylcholine receptor subunits in the brain of HIV-1 transgenic rats given chronic nicotine treatment , 2016, Journal of NeuroVirology.

[18]  C. Mactutus,et al.  Progression of temporal processing deficits in the HIV-1 transgenic rat , 2016, Scientific Reports.

[19]  David J. Volsky,et al.  HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment , 2016, Nature Reviews Neurology.

[20]  D. Maric,et al.  Characterization of neuropathology in the HIV-1 transgenic rat at different ages , 2016, Journal of Neuroimmunology.

[21]  D. Feuerbach,et al.  Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders , 2016, Cellular and Molecular Life Sciences.

[22]  C. Apetrei,et al.  Animal Models for HIV Cure Research , 2016, Front. Immunol..

[23]  T. Frieden,et al.  Applying Public Health Principles to the HIV Epidemic--How Are We Doing? , 2015, The New England journal of medicine.

[24]  J. Lasalde-Dominicci,et al.  The α7-nicotinic receptor is upregulated in immune cells from HIV-seropositive women: consequences to the cholinergic anti-inflammatory response , 2015, Clinical & translational immunology.

[25]  H. Brontë-Stewart,et al.  Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention – A Comparison with Parkinson’s Disease , 2015, Neuropsychology Review.

[26]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2016 , 2015, MMWR. Morbidity and mortality weekly report.

[27]  Li Yue-chun,et al.  Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3 , 2015, Scientific Reports.

[28]  Li Yue-chun,et al.  Erratum: Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3 , 2015, Scientific Reports.

[29]  B. Becher,et al.  Innate and adaptive immune responses in the CNS , 2015, The Lancet Neurology.

[30]  H. Lane,et al.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. , 2015, The New England journal of medicine.

[31]  M. Vigorito,et al.  The HIV-1 transgenic rat model of neuroHIV , 2015, Brain, Behavior, and Immunity.

[32]  Ming D. Li,et al.  Nicotine attenuates the effect of HIV-1 proteins on the neural circuits of working and contextual memories , 2015, Molecular Brain.

[33]  J. Lasalde-Dominicci,et al.  Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation , 2015, Journal of Neuroimmune Pharmacology.

[34]  R. Cohen,et al.  HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? , 2015, Alzheimer's Research & Therapy.

[35]  J. Skarbinski,et al.  Cigarette Smoking Prevalence Among Adults With HIV Compared With the General Adult Population in the United States , 2015, Annals of Internal Medicine.

[36]  W. Banks,et al.  Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications , 2015, Brain, Behavior, and Immunity.

[37]  F. Speizer,et al.  Smoking and mortality--beyond established causes. , 2015, The New England journal of medicine.

[38]  K. Sliva Latest animal models for anti-HIV drug discovery , 2015, Expert opinion on drug discovery.

[39]  M. Paiardini,et al.  Animal models in HIV cure research , 2015, Journal of virus eradication.

[40]  S. Abbondanzo,et al.  HIV-1 Transgenic Rats Display Alterations in Immunophenotype and Cellular Responses Associated with Aging , 2014, PloS one.

[41]  M. Pentella,et al.  Laboratory testing for the diagnosis of HIV infection : updated recommendations , 2014 .

[42]  M. Weiner,et al.  Smoking and increased Alzheimer's disease risk: A review of potential mechanisms , 2014, Alzheimer's & Dementia.

[43]  W. Ho,et al.  Animal models to study Mycobacterium tuberculosis and HIV co-infection. , 2014, Dong wu xue yan jiu = Zoological research.

[44]  C. Garlanda,et al.  The interleukin-1 family: back to the future. , 2013, Immunity.

[45]  Jeremy Luban,et al.  Overcoming current limitations in humanized mouse research. , 2013, The Journal of infectious diseases.

[46]  Anil Kumar,et al.  Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes , 2013, Expert opinion on drug metabolism & toxicology.

[47]  C. Kahler,et al.  The effects of cigarette smoking on learning and memory performance among people living with HIV/AIDS , 2013, AIDS care.

[48]  Ming D. Li,et al.  RNA Deep Sequencing Analysis Reveals That Nicotine Restores Impaired Gene Expression by Viral Proteins in the Brains of HIV-1 Transgenic Rats , 2013, PloS one.

[49]  Shaolin Wang,et al.  Transcriptome Sequencing of Gene Expression in the Brain of the HIV-1 Transgenic Rat , 2013, PloS one.

[50]  B. Nordestgaard,et al.  Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  Sulie L. Chang,et al.  Ethanol Concentration-Dependent Alterations in Gene Expression During Acute Binge Drinking in the HIV-1 Transgenic Rat , 2013, Alcoholism, clinical and experimental research.

[52]  S. Horvath,et al.  Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer’s disease , 2013, BMC Medical Genomics.

[53]  C. Mactutus,et al.  Neurobehavioral alterations in HIV-1 transgenic rats: Evidence for dopaminergic dysfunction , 2013, Experimental Neurology.

[54]  N. Petrosillo,et al.  Smoking and HIV: time for a change? , 2013, BMC Medicine.

[55]  T. Olsson,et al.  Nicotine might have a protective effect in the etiology of multiple sclerosis , 2013, Multiple sclerosis.

[56]  R. Akkina,et al.  New generation humanized mice for virus research: comparative aspects and future prospects. , 2013, Virology.

[57]  Ming D. Li,et al.  Identification and Characterization of Poly(I:C)-induced Molecular Responses Attenuated by Nicotine in Mouse Macrophages , 2013, Molecular Pharmacology.

[58]  Alejandra Borjabad,et al.  Common Transcriptional Signatures in Brain Tissue from Patients with HIV-Associated Neurocognitive Disorders, Alzheimer’s Disease, and Multiple Sclerosis , 2012, Journal of Neuroimmune Pharmacology.

[59]  Ming D. Li,et al.  Modulation of innate immune-related pathways in nicotine-treated SH-SY5Y cells , 2012, Amino Acids.

[60]  Anthony S Fauci,et al.  Toward an AIDS-free generation. , 2012, JAMA.

[61]  R. Speck,et al.  Modeling HIV infection and therapies in humanized mice. , 2012, Swiss medical weekly.

[62]  M. Quik,et al.  Nicotine as a potential neuroprotective agent for Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[63]  M. Aksenov,et al.  Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. , 2012, Current HIV research.

[64]  M. Kaul,et al.  Genetic Knockouts Suggest a Critical Role for HIV Co-Receptors in Models of HIV gp120-Induced Brain Injury , 2012, Journal of Neuroimmune Pharmacology.

[65]  Sulie L. Chang,et al.  Behavioral and Molecular Evidence for a Feedback Interaction Between Morphine and HIV-1 Viral Proteins , 2012, Journal of Neuroimmune Pharmacology.

[66]  H. Lando,et al.  Smoking and HIV: Prevalence, Health Risks, and Cessation Strategies , 2012, Current HIV/AIDS Reports.

[67]  S. Shimohama,et al.  α7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's disease. , 2012, Current drug targets.

[68]  Ulf Andersson,et al.  Reflex principles of immunological homeostasis. , 2012, Annual review of immunology.

[69]  A. Nath,et al.  Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis , 2012, Disease Models & Mechanisms.

[70]  Mamoru Ito,et al.  Current advances in humanized mouse models , 2012, Cellular and Molecular Immunology.

[71]  A. Cesario,et al.  Nicotine: specific role in angiogenesis, proliferation and apoptosis , 2012, Critical reviews in toxicology.

[72]  C. D. Fowler,et al.  Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. , 2011, Biochemical pharmacology.

[73]  Johnny J. He,et al.  HIV-1 Tat Protein Promotes Neuronal Dysfunction through Disruption of MicroRNAs* , 2011, The Journal of Biological Chemistry.

[74]  J. Otis,et al.  Chronic alcohol ingestion exacerbates skeletal muscle myopathy in HIV-1 transgenic rats , 2011, AIDS research and therapy.

[75]  D. Kolson,et al.  Current understanding of HIV-associated neurocognitive disorders pathogenesis. , 2011, Current opinion in neurology.

[76]  A. Gomez,et al.  Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats , 2011, Pharmacology Biochemistry and Behavior.

[77]  A. Venkatesan,et al.  Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease , 2011, Neurobiology of Disease.

[78]  B. Ances,et al.  Pathogenesis of HIV in the Central Nervous System , 2010, Current HIV/AIDS reports.

[79]  Linda Chang,et al.  Methamphetamine-Induced Behavioral and Physiological Effects in Adolescent and Adult HIV-1 Transgenic Rats , 2010, Journal of Neuroimmune Pharmacology.

[80]  Ming D. Li,et al.  Nicotinic Modulation of Innate Immune Pathways Via α7 Nicotinic Acetylcholine Receptor , 2010, Journal of Neuroimmune Pharmacology.

[81]  D. Baker,et al.  Inflammation in neurodegenerative diseases , 2010, Immunology.

[82]  M. Vigorito,et al.  The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART , 2010, Journal of Neuroimmunology.

[83]  M. Vigorito,et al.  Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat , 2009, Journal of NeuroVirology.

[84]  M. McCormack,et al.  Effect of cigarette smoking on HIV acquisition, progression, and mortality. , 2009, AIDS education and prevention : official publication of the International Society for AIDS Education.

[85]  K. Tracey,et al.  Cholinergic control of inflammation , 2009, Journal of internal medicine.

[86]  K. Tracey Reflex control of immunity , 2009, Nature Reviews Immunology.

[87]  T. Ikezu,et al.  The Comorbidity of HIV-Associated Neurocognitive Disorders and Alzheimer’s Disease: A Foreseeable Medical Challenge in Post-HAART Era , 2009, Journal of Neuroimmune Pharmacology.

[88]  F. Shi,et al.  Nicotine and inflammatory neurological disorders , 2009, Acta Pharmacologica Sinica.

[89]  Linda Chang,et al.  Methamphetamine-Induced Behavioral Sensitization Is Enhanced in the HIV-1 Transgenic Rat , 2009, Journal of Neuroimmune Pharmacology.

[90]  M. Stämpfli,et al.  How cigarette smoke skews immune responses to promote infection, lung disease and cancer , 2009, Nature Reviews Immunology.

[91]  Michael Koval,et al.  Chronic alcohol ingestion exacerbates lung epithelial barrier dysfunction in HIV‐1 transgenic rats , 2009, Alcoholism, clinical and experimental research.

[92]  J. Ingram Nicotine: does it have a role in the treatment of skin disease? , 2009, Postgraduate Medical Journal.

[93]  E. Hirsch,et al.  Neuroinflammation in Parkinson's disease: a target for neuroprotection? , 2009, The Lancet Neurology.

[94]  Shun Shimohama,et al.  Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models. , 2009, Biological & pharmaceutical bulletin.

[95]  F. Shi,et al.  Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity1 , 2009, The Journal of Immunology.

[96]  N. Benowitz Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. , 2009, Annual review of pharmacology and toxicology.

[97]  Athina Markou,et al.  Neurobiology of nicotine dependence , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[98]  Rajagopal N. Aravalli,et al.  Potentiation of HIV-1 Expression in Microglial Cells by Nicotine: Involvement of Transforming Growth Factor-β1 , 2008, Journal of Neuroimmune Pharmacology.

[99]  N. Sonenberg,et al.  Translational control of the innate immune response through IRF-7 , 2008, Nature.

[100]  M. Smith,et al.  Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. , 2007, CNS & neurological disorders drug targets.

[101]  Gary E. Swan,et al.  The Effects of Tobacco Smoke and Nicotine on Cognition and the Brain , 2007, Neuropsychology Review.

[102]  M. Vigorito,et al.  Spatial Learning and Memory in HIV-1 Transgenic Rats , 2007, Journal of Neuroimmune Pharmacology.

[103]  O. Selnes,et al.  Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment , 2006, Journal of NeuroVirology.

[104]  M. Kurokawa,et al.  Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I‐κB phosphorylation and nuclear factor‐κB transcriptional activity through nicotinic acetylcholine receptor α7 , 2006 .

[105]  F. Joseph McClernon,et al.  Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial , 2006, Psychopharmacology.

[106]  Mardge H. Cohen,et al.  Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. , 2006, American journal of public health.

[107]  E. Longhi,et al.  Failure to eradicate HIV despite fully successful HAART initiated in the first days of life. , 2006, The Journal of pediatrics.

[108]  P. Rueda-Orozco,et al.  Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats , 2006, Neuroscience Letters.

[109]  N. Rothwell,et al.  The role of inflammation in CNS injury and disease , 2006, British journal of pharmacology.

[110]  Andrea Scozzafava,et al.  Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome. , 2005, Current pharmaceutical design.

[111]  J. Virtamo,et al.  Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension , 2005, BMC Medical Genetics.

[112]  K. Tracey,et al.  Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis , 2004, Nature Medicine.

[113]  B. Giunta,et al.  Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120 , 2004, Brain Research Bulletin.

[114]  M. Reitz,et al.  HIV-1 transgenic rats develop T cell abnormalities. , 2004, Virology.

[115]  F. Denaro,et al.  A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy. , 2003, Kidney international.

[116]  Yiwen Ruan,et al.  Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. , 2003, The American journal of pathology.

[117]  N. Sacktor,et al.  Human immunodeficiency virus-associated dementia: An evolving disease , 2003, Journal of NeuroVirology.

[118]  Howard L. Weiner,et al.  Inflammation and therapeutic vaccination in CNS diseases , 2002, Nature.

[119]  N. Sacktor The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. , 2002, Journal of neurovirology.

[120]  A. Nath Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. , 2002, The Journal of infectious diseases.

[121]  A. Minagar,et al.  The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis , 2002, Journal of the Neurological Sciences.

[122]  E. Perry,et al.  Chronic nicotine treatment reduces β‐amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw) , 2002, Journal of neurochemistry.

[123]  P. Riederer,et al.  Parkinsonism in HIV dementia , 2002, Journal of Neural Transmission.

[124]  M. Sopori,et al.  Effects of cigarette smoke on the immune system , 2002, Nature Reviews Immunology.

[125]  M. Reitz,et al.  An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[126]  S. Vijayaraghavan,et al.  Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[127]  Edward D Levin,et al.  Cognitive effects of nicotine , 2001, Biological Psychiatry.

[128]  Hui-Xin Wang,et al.  Smoking and Parkinson’s and Alzheimer’s disease: review of the epidemiological studies , 2000, Behavioural Brain Research.

[129]  H. Forman,et al.  Molecular Mechanism of Decreased Glutathione Content in Human Immunodeficiency Virus Type 1 Tat-transgenic Mice* , 2000, The Journal of Biological Chemistry.

[130]  D. Montefiori,et al.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.

[131]  D. Overstreet,et al.  Antidepressant effects of nicotine in an animal model of depression , 1999, Psychopharmacology.

[132]  L. Mucke,et al.  Transgenic mice with cerebral expression of human immunodeficiency virus type-1 coat protein gp120 show divergent changes in short- and long-term potentiation in CA1 hippocampus , 1998, Neuroscience.

[133]  M. Jaakkola,et al.  Assessment of exposure to environmental tobacco smoke. , 1997, The European respiratory journal.

[134]  Y. Itoyama,et al.  [Pathogenesis of HIV-1-associated-neurologic diseases]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.

[135]  A. Matthew,et al.  Bovine immunodeficiency virus: molecular biology and virus-host interactions , 1994 .

[136]  L. Mucke,et al.  Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice , 1994, Nature.

[137]  M. Rustici,et al.  Binding of HIV‐1 gp120 to the nicotinic receptor , 1992, FEBS letters.

[138]  R. Purcell,et al.  Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[139]  R. Custer,et al.  A severe combined immunodeficiency mutation in the mouse , 1983, Nature.

[140]  Brian A. King,et al.  Current Cigarette Smoking Among Adults - United States, 2005-2015. , 2016, MMWR. Morbidity and mortality weekly report.

[141]  K. Arga,et al.  Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. , 2016, Omics : a journal of integrative biology.

[142]  Ming D. Li,et al.  NeuroHIV and use of addictive substances. , 2014, International review of neurobiology.

[143]  Sulie L. Chang,et al.  Age- and ethanol concentration-dependent effects of acute binge drinking in the HIV-1 transgenic rat. , 2013, Alcoholism, clinical and experimental research.

[144]  M. Vigorito,et al.  Morphine-induced conditioned place preference and associated behavioural plasticity in HIV-1 transgenic rats. , 2012, International journal of clinical and experimental medicine.

[145]  Jun Kawamata,et al.  Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases. , 2011, Journal of Alzheimer's disease : JAD.

[146]  O. Selnes,et al.  Please Scroll down for Article Journal of Neurovirology Associations of Cigarette Smoking with Viral Immune and Cognitive Function in Human Immunodeficiency Virus-seropositive Women Associations of Cigarette Smoking with Viral Immune and Cognitive Function in Human Immunodeficiency Virus–seropositiv , 2022 .

[147]  N. Benowitz Nicotine addiction. , 2010, The New England journal of medicine.

[148]  E. Albuquerque,et al.  Mammalian nicotinic acetylcholine receptors: from structure to function. , 2009, Physiological reviews.

[149]  M. Picciotto,et al.  Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease. , 2008, Frontiers in bioscience : a journal and virtual library.

[150]  M. Kurokawa,et al.  Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. , 2006, Clinical and experimental immunology.

[151]  Francisco González-Scarano,et al.  The neuropathogenesis of AIDS , 2005, Nature Reviews Immunology.

[152]  F. Krebs,et al.  HIV-1-associated central nervous system dysfunction. , 2000, Advances in pharmacology.

[153]  K. Nave,et al.  Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene. , 1995, AIDS research and human retroviruses.

[154]  J. Palca Nicotine addiction , 1988, Nature.